ASO Author Reflections: Neuron Projection Guidance—A transcriptomic perspective on tumor-induced neural recruitment in breast cancer
Kei Kawashima, Kohei Chida, Masanori Oshi, Akimitsu Yamada et autres
0 citationsAnnals of Surgical Oncology
Kazutaka Narui
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
194Publications signalées
1331Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Breast Cancer Treatment StudiesBreast Implant and ReconstructionCancer Treatment and PharmacologyReconstructive Surgery and Microvascular TechniquesAdvanced Breast Cancer Therapies
Publications récentes
ASO Visual Abstract: A Neuron Projection Guidance Signature Associates With Immune-Cold Tumor Microenvironment and Poor Outcomes in Breast Cancer
Kei Kawashima, Kohei Chida, Masanori Oshi, Akimitsu Yamada et autres
0 citationsAnnals of Surgical Oncology
Association of tumor Schwann cells with epithelial-mesenchymal transition and immune-suppressive microenvironment in triple-negative breast cancer
Kei Kawashima, Eslam A. Elsaedy, Masanori Oshi, Akimitsu Yamada et autres
0 citationsBreast Cancer Research and Treatment
A Neuron Projection Guidance Signature Associates with Immune-Cold Tumor Microenvironment and Poor Outcomes in Breast Cancer
Kei Kawashima, Kohei Chida, Masanori Oshi, Akimitsu Yamada et autres
2 citationsAnnals of Surgical Oncology
Abemaciclib plus endocrine therapy in chemotherapy-treated patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer
Kazutaka Narui, Kana Miyahara, Yukari Uemura, Akimitsu Yamada et autres
0 citationsBreast Cancer
The clinical relevance of apocrine morphology in breast cancer depends on the estrogen receptor status
Kei Kawashima, Masanori Oshi, Akimitsu Yamada, Kazutaka Narui et autres
0 citationsnpj Breast Cancer
Real-world data for a CDK4/6 inhibitor, palbociclib, as 1st- or 2nd-line therapy in HR+/HER2− metastatic breast cancer: a multicenter prospective cohort study
Takashi Ishikawa, Yukari Uemura, Hirohito Seki, Masahiro Kitada et autres
0 citationsBreast Cancer Research
Risk stratification and age-related disparities with abemaciclib responses in early ER-positive/HER2-negative breast cancer.
Masanori Oshi, Adrienne Groman, Takako Kuroda, Takuho Okamura et autres
0 citationsJournal of Clinical Oncology
Association of Schwann cells with immune-cold tumor microenvironment in triple-negative breast cancer.
Kei Kawashima, Masanori Oshi, Akimitsu Yamada, Kazutaka Narui et autres
0 citationsJournal of Clinical Oncology
Cell proliferation, immune cell infiltration, and survival outcomes in sarcomas with high cancer-associated fibroblast expression.
Olivia Martin, Kei Kawashima, Masanori Oshi, Rongrong Wu et autres
1 citationJournal of Clinical Oncology
ILCness to stratify lobular-like breast cancer biology and as an outcome independent of CDH1 mutation in early ER-positive/HER2-negative breast cancer.
Masanori Oshi, Sasagu Kurozumi, Mayu Hizume, Akimitsu Yamada et autres
0 citationsJournal of Clinical Oncology
The development of Breast Apocrine Carcinoma (BAC) score that distinguishes breast and cutaneous apocrine carcinomas
Kei Kawashima, Akimitsu Yamada, Eleanor A. Fallon, Ryo Fujita et autres
0 citationsResearch Square
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.